ConductScience.org, home

Gene · 9476

Papers2,888

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

201 to 220 of 2,888

Download this page as JSON
TitleJournalYearPMIDFound bySource
Intrapulmonary Biphasic Mesothelioma Misdiagnosed as Adenocarcinoma: Case Report and a Potential Diagnostic Pitfall.Onco Targets Ther202439525355PubTator, text miningPubMed
[Clinicopathological features of primary pulmonary hyalinizing clear cell carcinoma and its diagnostic pitfalls in biopsy specimens].Zhonghua Bing Li Xue Za Zhi202439482049PubTator, text miningPubMed
[Histopathological diagnosis of pulmonary sclerosing pneumocytoma in needle biopsy specimens].Zhonghua Bing Li Xue Za Zhi202439482047PubTator, text miningPubMed
A Case of CUP with Malignant Pleural Effusion: Overcoming Diagnostic and Therapeutic Hurdles with Chemotherapy.Case Rep Oncol202439474546PubTator, text miningPubMed
Towards personalized vaccines.Front Immunol202439421749PubTator, text miningPubMed
Collaborative governance of an integrated system for collecting contributions for social health insurance, pension, and taxes from the informal sector: a synthesis of stakeholder perspectives.BMC Health Serv Res202439420332PubTator, text miningPubMed
Development of a Second Primary Lung Cancer Following a Primary Breast Cancer: A Case Series.J Investig Med High Impact Case Rep202439390783PubTator, text miningPubMed
Primary adenocarcinoma of the spermatic cord: a case report and review of the literature.Diagn Pathol202439385147PubTator, text miningPubMed
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities.Virchows Arch202439377914PubTator, text miningPubMed
A case of masquerade syndrome caused by metastatic iris tumor diagnosed by a high CEA level in the aqueous humor and iris biopsy.Diagn Pathol202439334444PubTator, text miningPubMed
Surgical indication and management of obstructive colonic metastasis from primary lung adenocarcinoma: report of a case and review of the literature.Surg Case Rep202439292398PubTator, text miningPubMed
Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancer.Transl Lung Cancer Res202439263013PubTator, text miningPubMed
Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates.J Immunother Precis Oncol202439219997PubTator, text miningPubMed
[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].Zhonghua Yi Xue Za Zhi202439193606PubTator, text miningPubMed
Unveiling Commonalities: Exploring Shared Characteristics in Clear-Cell Carcinomas of the Gynecologic Tract.Clin Cancer Res202439141515PubTator, text miningPubMed
Utility of ER, p53, CEA and Napsin A in Histological Subtyping of Endometrial Carcinoma and Their Correlation with Clinicopathological Prognostic Parameters: Experience from a Referral Institute.Iran J Pathol202439118789PubTator, text miningPubMed
Comparison of antigenicity between frozen section vs non-frozen section tissue blocks: An immunohistochemical study of antibodies commonly used in gynecologic pathology.Am J Clin Pathol202439110415PubTator, text miningPubMed
Papillary adenoma of the lung: A case report and literature review.Exp Ther Med202439091411PubTator, text miningPubMed
Improving histotyping precision: The impact of immunohistochemical algorithms on epithelial ovarian cancer classification.Hum Pathol202439084566PubTator, text miningPubMed
Unlocking Precise Lung Cancer Detection Through Minimal Panel Immunostaining in Small Biopsy Samples.Cureus202439070322PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/9476/papers?page=11